Wells Fargo & Company Merck & Co., Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Merck & Co., Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 14,917,821 shares of MRK stock, worth $1.46 Billion. This represents 0.39% of its overall portfolio holdings.

Number of Shares

14,917,821

Previous 15,617,960 4.48%

Holding current value

$1.46 Billion

Previous $1.93 Billion 12.38%

% of portfolio

0.39%

Previous 0.48%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$111.15 - $128.97 $77.8 Million - $90.3 Million	-700,139 Reduced 4.48%	14,917,821 $1.69 Billion
Q2 2024 Aug 13, 2024	SELL	$123.8 - $132.96 $93.9 Million - $101 Million	-758,740 Reduced 4.63%	15,617,960 $1.93 Billion
Q1 2024 May 10, 2024	BUY	$113.24 - $131.95 $12.9 Million - $15.1 Million	114,181 Added 0.7%	16,376,700 $2.16 Billion
Q4 2023 Feb 09, 2024	SELL	$100.18 - $109.02 $15.2 Million - $16.5 Million	-151,738 Reduced 0.92%	16,262,519 $1.77 Billion
Q3 2023 Nov 13, 2023	SELL	$102.95 - $114.33 $122 Million - $136 Million	-1,185,625 Reduced 6.74%	16,414,257 $1.69 Billion
Q2 2023 Aug 15, 2023	SELL	$108.61 - $118.38 $29.5 Million - $32.1 Million	-271,419 Reduced 1.52%	17,599,882 $2.03 Billion
Q1 2023 May 12, 2023	SELL	$102.94 - $114.86 $46.7 Million - $52.1 Million	-453,650 Reduced 2.48%	17,871,301 $1.9 Billion
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $50 Million - $64.1 Million	-572,173 Reduced 3.03%	18,324,951 $2.03 Billion
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $17.5 Million - $19.6 Million	-206,536 Reduced 1.08%	18,897,124 $1.63 Billion
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $77.5 Million - $87.8 Million	-928,242 Reduced 4.63%	19,103,660 $1.74 Billion
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $99.5 Million - $112 Million	1,354,007 Added 7.25%	20,031,902 $1.64 Billion
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $160 Million - $200 Million	-2,212,150 Reduced 10.59%	18,677,895 $1.43 Billion
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $35.8 Million - $39.4 Million	-499,610 Reduced 2.34%	20,890,045 $1.57 Billion
Q2 2021 Aug 16, 2021	SELL	$70.31 - $77.77 $67.3 Million - $74.5 Million	-957,686 Reduced 4.29%	21,389,655 $1.66 Billion
Q1 2021 May 13, 2021	SELL	$68.86 - $81.11 $4.52 Million - $5.33 Million	-65,673 Reduced 0.29%	22,347,341 $1.72 Billion
Q4 2020 Feb 09, 2021	SELL	$71.77 - $79.65 $34.6 Million - $38.4 Million	-482,597 Reduced 2.11%	22,413,014 $1.83 Billion
Q3 2020 Nov 05, 2020	SELL	$73.18 - $82.95 $47.4 Million - $53.7 Million	-647,926 Reduced 2.75%	22,895,611 $1.9 Billion
Q2 2020 Aug 13, 2020	BUY	$70.42 - $80.13 $39.5 Million - $44.9 Million	560,767 Added 2.44%	23,543,537 $1.82 Billion
Q1 2020 May 14, 2020	BUY	$63.36 - $87.82 $1.46 Billion - $2.02 Billion	22,982,770 New	22,982,770 $1.77 Billion

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Merck & Co., Inc. Transaction History